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Background: The standard management in patients with thyroid nodules is to assess the risk of malignancy, based
on cytological examination. On the other hand, there are thyroid patterns of ultrasound (US) image, associated with
an increased risk of malignancy.
The aim of our study was to create a diagnostic algorithm that would employ both data from US examination
(expressed by a total score, according to our scoring system) and FNAB results, classified according to Bethesda
system (The Bethesda System for Reporting Thyroid Cytopathology - TBSRTC categories).
Material and methods: 100 thyroid cancer foci (94 papillary carcinomas, 4 medullary carcinomas, 2
undifferentiated carcinomas) and 100 benign focal lesions were selected during postoperative histopathological
examination of thyroid glands excised during surgery from 111 patients. The corresponding US images of each
lesion – performed in the course of preoperative diagnostics – were evaluated for the presence of seven (7)
different features in US image, suggesting a malignant character of lesion, viz. vascularity, i.e., the increased central
intranodular blood flows, microcalcifications, “taller-than-wide” orientation, solid composition, hypoechogenicity,
irregular margin and either absence of peripheral halo or the presence of outer shell of uneven thickness,
surrounding the lesion. The sensitivity, specificity, positive predictive values, negative predictive values and odds
ratios for each US feature were calculated.
Results: In US image of the analyzed cancer foci, we obtained the following values of odds ratio for each of the
above mentioned features suggesting malignancy: “taller-than-wide” orientation - odds ratio - 301.0,
microcalcifications - 24.67, increased intranodular vascularity - 20.44, hypoechogenicity - 18.61, irregular margins -
7.81, absence of halo - 5.88, and solid composition - 4.16.
Taking into account our own experience and the present data, in juxtaposition with the opinions of other authors,
we propose a division of US features into 3 groups of different prognostic importance, expressed by a total score
calculated based on our scoring system. Accordingly, microcalcifications, “taller-than-wide” orientation, the increased
intranodular vascularity, and hypoechogenicity constitute one group - each of the features in this group is awarded
1 point. In turn, the characteristics of minor prognostic importance, such as irregular margin, absence of halo, solid
composition, and large size (a diameter longer than 3.0 cm) - are associated with the granting 0.5 points each. The
most important prognostic features – a rapid growth (enlargement) of nodules/focal lesions and a presence of
pathologically altered lymph nodes are associated with the granting 3 points for each.
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Our scoring system can be applied in order to better assessment of thyroid US patterns in whole. In patients with a
total score ranging from 0 < 4 points there is US pattern of a low risk of malignancy, with ≥ 4 < 7 points -
intermediate risk, and in patients with a score ≥ 7 points – a high risk in question.
Conclusion: Complementary use of our scoring system and FNAB TBSRTC categories can help to make optimal
clinical decisions as regards the selection of treatment strategy.Background
Common use of ultrasonography (US) in the diagnostics
of thyroid diseases and of other diseases in the neck re-
gion caused rapid increase of the number of detected im-
palpable, asymptomatic lesions in the gland. According to
some authors, it allows to visualize 10 times more US le-
sions than the number of palpable nodules detected dur-
ing the physical examination [1-3]. It creates diagnostic
and therapeutic dilemmas, dominated by the question:
what is the most proper medical management – observa-
tion and careful monitoring of existing nodule, or – the
opposite - referring the patients for surgery. While follow
up, the most frequent way to proceed are the repeated US
examination and a fine needle aspiration biopsy (FNAB).
Even though the biopsy is considered by many doctors as
a basis for further monitoring, performing FNAB of any
identified lesions may not be prudent [4,5]. It happens that
FNAB confirms the benign nature of the lesion and,
nevertheless, it is quite frequently repeated (often many
times) in spite of the fact that US image pattern does not
change during a long-term observation. On the other
hand, the surgical treatment in patients with obvious clin-
ical signs and symptoms of malignant neoplastic disease is
sometimes delayed because of unnecessary diagnostic pro-
cedures (e.g., due to awaiting for recommended time after
which FNAB should be performed again). Thus, the endo-
crinologist - while diagnosing the thyroid nodule - cannot
forget a question of fundamental importance – what is a
bigger threat to the patients – observation, i.e., monitoring
of lesion and live with the existing thyroid nodule or
subjecting the patient to surgical treatment of his/her
thyroid.
The aim of our study was to create an algorithm that
would employ both data from US examination and
FNAB results, classified according to Bethesda recom-
mendations (The Bethesda System for Reporting Thy-
roid Cytopathology - TBSRTC categories), in order to
optimise diagnostic and therapeutic management in case
of nodules/US focal lesions in the thyroid [6].
Methods
The algorithm was developed on the basis of prospective
diagnostics in patients with nodules/US focal lesions of
the thyroid, hospitalized in the Department of Endocrin-
ology and Metabolic Diseases, in the time period fromJanuary 2008 to June 2012, who – then - were referred for
surgery. At the same time, data of other authors on
assessing the risk of thyroid malignancy, based on US
characteristics, FNAB results, family medical history, and
- above all - clinical signs and symptoms were considered.
100 thyroid cancer foci (94 papillary carcinomas, 4
medullary carcinomas, 2 undifferentiated carcinomas) and
100 benign focal lesions were selected during postopera-
tive histopathological examination of thyroid glands ex-
cised during surgery carried out in 111 patients, aged 23
to 79 years (mean age – 57.0 years). The corresponding
US images of each lesion – obtained in the course of pre-
operative diagnostics – were evaluated in order to assess
seven (7) US characteristics, the most useful in differenti-
ating benign and malignant lesions [7-10]. All examina-
tions were performed by the same diagnostician, with
extensive experience in thyroid US, using Toshiba Aplio
XG US device with a linear probe PLT 1204 BT 12–
18 MHz. An evaluation of focal lesions was carried out in
the grey scale (B-mode), also with use of Power-Doppler
method.
The following US features were subjected to analysis
(for each characteristics - an appearance suggesting a
malignant character of lesion is specified, followed by
the respective image of the same feature, speaking for its
benign nature):
1. Vascularity - defined as the presence of irregular
chaotic intranodular hypervascularity; also images of
a total absence of blood flow in hypoechogenic, solid
lesions were included into that group; in contrast to
the peripheral, subcapsular blood flows, suggesting
benign lesions [11,12].
2. Calcifications - assessed as the presence of
microcalcifications, also their coexistence with other
forms of calcifications (e.g., dystrophic); in contrast
to the absence of calcifications, the latter suggesting
benign nature of lesions.
3. Orientation - “taller than wide” shape of lesion in
transverse and/or longitudinal planes; in contrast to
all other lesion shapes.
4. Composition - solid lesions, also mixed lesions with
cystic component not exceeding 10% of the volume;
in contrast to lesions with cystic parts greater than
10% of total volume and/or to solely cystic lesions.
Table 1 Distribution of US characteristics in malignant and benign thyroid lesions; p values indicating a statistical
significance are marked by bold
Parameter No. of cases (%) Malignant lesions Benign lesions p value
No. of cases (%) No. of cases (%)
Vascularity
Intranodular and increased or completely absent 150 (75.0) 96 (64.0) 54 (46.0) <0.0001
Peripheral, subcapsular 50 (25.0) 4 (8.0) 46 (92.0)
Microcalcifications
Positive 128 (64.0) 93 (72.7) 35 (27.3) <0.0001
Negative 72 (36.0) 7 (9.7) 65 (90.2)
Orientation
Taller-than-wide 88 (44.0) 86 (97.7) 2 (2.3) <0.0001
Wider-than-tall or of other shape 112 (56.0) 14 (12.5) 98 (87.5)
Composition
Solid 173 (86.5) 94 (54.3) 79 (65.7) 0.0032
Mixed 27 (23.5) 6 (22.2) 21 (77.8)
Echogenicity
Hypoechogenic 106 (53.0) 84 (79.2) 22 (20.1) <0.0001
Isoechogenic 94 (47.0) 16 (17.0) 78 (83.0)
Margins
Irregular 107 (53.5) 77 (71.9) 30 (28.1) <0.0001
Well circumscribed 93 (46.5) 23 (24.7) 70 (75.3)
Peripheral Halo
Absent or irregular, thick 111 (55.0) 76 (68.0) 35 (32.0) <0.0001
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defined as a reduced (“darker”) echogenicity (similar
to the echogenicity of muscles, surrounding the
thyroid); in contrast to normal thyroid echogenicity
(isoechogenicity) in benign lesions.
6. Margin - blurred and poorly defined; in contrast to
well-differentiated regular margin.
7. Halo - the absence of halo, or the presence of outer
shell (rim) of uneven thickness that surrounds the
lesion; in contrast to the presence of thin, regular
halo which speaks for a benign nature of lesion.ble 2 Values of sensitivity, specificity, PPV and NPV of the
rameter Sensitivity (%) Sp
scularity 96 (90–99) 4
icrocalcifications 93 (86–97) 6
rientation 86 (77–92) 9
mposition 94 (87–97) 2
hogenicity 84 (75–90) 7
argins 77 (67–84) 7
ripheral Halo 76 (66–84) 6
e 95% confidence intervals are given in the brackets.Statistical analysis
The statistical analysis was performed with use of the
Prism 5.0 software (GraphPad, La Jolla, USA). Fisher
exact test was used to analyze distribution of the
obtained results between the examined benign and ma-
lignant lesions. For each tested variable – the sensitivity,
specificity, positive predictive values (PPV), negative pre-
dictive values (NPV) and odds ratios were estimated.
Additionally, the 95% confidence intervals of these pa-
rameters were determined. The results were regarded as
significant for p < 0.05.analyzed US characteristics (parameters)
ecificity (%) PPV (%) NPV (%)
6 (36–56) 64 (56–72) 92 (80–98)
5 (54–74) 73 (64–80) 90 (80–96)
8 (93–99) 97 (92–99) 87 (80–93)
1 (13–30) 54 (46–61) 77 (57–91)
8 (68–85) 79 (70–86) 82 (73–89)
0 (60–78) 72 (62–80) 75 (65–83)
5 (56–74) 68 (59–77) 73 (62–82)
Figure 1 Odds ratios of analyzed US characteristics in diagnostics of malignant thyroid lesions. The values on the figure indicate the
median odds ratio, with neighboring dots indicating the boundaries of 95% confidence intervals.
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The comparison of distribution of US characteristics,
assessed in two (2) analyzed groups, showed the pres-
ence of significant statistical differences in the frequency
of their occurrence, depending on the histopathological
diagnosis (benign vs malignant lesions) (Table 1).
Table 2 presents the obtained values of sensitivity and
specificity, also positive predictive values (PPV) and
negative predictive values (NPV) of the analyzed param-
eters. Our results are comparable with data from reports
of other authors [8,9,12-16].
Simultaneously, the assessment of the odds ratios of
thyroid cancer diagnosis, in the presence of the particu-
lar characteristics evaluated in each case, showed the in-
creased risk of malignancy. The highest values of odds
ratios were recorded in case of lesions "taller-than-wide"
in shape in transverse and/or longitudinal planes, also
the presence of microcalcifications, the incorrect patternTable 3 Summary of points awarded depending on the
US characteristics
Most important characteristic (each feature – 3 points)
G Growth of nodules (resulting in rapid enlargement)
L Pathologically altered lymph nodes
Major prognostic characteristic (each feature – 1 point)
O Orientation (shape)
C1 Calcifications (especially microcalcifications)
V Vascularity (intranodular increased or absent)
E Echogenicity (in particular hypoechogenicity)
Minor prognostic characteristic (each feature – 0.5 point)
M Margin (blurred and poorly defined)
H Halo (absent or irregular and thick)
C2 Composition (solid)
D Diameter (longer than 3.0 cm)of vascularisation (intranodular and increased or com-
pletely absent) and/or hypoechogenicity were related to
the increased cancer risk. This also applied - but to a
lesser extent - to the lesions such as solid composition,
the absence of halo, and blurred margins (Figure 1).
In addition, data from numerous reports of other au-
thors indicate an increased risk of malignancy, especially
in the case of:
– the rapid growth of thyroid nodules/focal lesions
[17] which is defined as a 20% increase in minimum
two dimensions (at least - 2 mm) in the follow-up
period shorter than 18 months [18];
– thyroid lesions coexisting with lymphadenopathy
that may suggest nodal metastases [19,20].
It is to be recalled that cervical US is the optimal
method for searching lymph node metastases [18]. This
examination allows to reveal more than 90% of the
current metastases [21], the presence of which is diag-
nosed in approximately 25% microcarcinomas and even
more frequently, up to 50% in larger tumours, with sig-
nificant extrathyroidal extension, viz. T4 tumour stage in
TNM scale [9,22]. However, it should be stressed that
the simultaneous presence of the thyroid tumour and
enlarged cervical lymph nodes does not necessarily con-
stitute evidence of a direct causal relation;Table 4 The scoring system of US patterns, applied for
thyroid nodules/focal lesions
Risk of malignancy, as assessed on the
basis of US pattern
A total score
Low risk 0 < 4 points
Intermediate risk ≥ 4 < 7 points
High risk ≥ 7 points














Figure 2 Low risk thyroid nodule/focal lesion US pattern. A. Ultrasound picture of the thyroid lesion (B-mode). The scoring system – 1.5
points (low risk US pattern 0 < 4 points); E – hypoechogenicity; C2 – solid composition; FNAB cytology in this case - category II TBSRTC;
management - observation and repeat FNAB examination after 18 months. B. Ultrasound picture of the thyroid lesion (Power Doppler), peripheral
blood flows.
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exceeding 3–4 cm [23]; in tumours of larger size -
follicular carcinomas are diagnosed more frequently
[23,24]. In these cases - FNAB, used as the sole
diagnostic test, does not allow formulation of the
final diagnosis and confirmation of malignant nature
of tumours and its result always must be evaluated
with reference to clinical and US examinations.
Three characteristics listed above (rapid growth, enlarged
lymph nodes, tumour size) have not been evaluated or
subjected to statistical calculations in our present study forthe reasons which we would like to explain. Follow-up of
changes in the size of the analyzed lesions was not possible
because the majority of US examinations were performed
directly prior to surgery, and the patients submitted to sur-
gical treatment were not previously hospitalised and diag-
nosed in our Department.
Due to the fact that the coexistence of thyroid lesions
and of abnormal lymph nodes was found exclusively in
case of malignant foci, we decided to exclude that fea-
ture from the statistical evaluation.
The diameter of all lesions examined by us did not ex-
ceed 3.0 cm, thus it was not possible to use the size of
Figure 3 Intermediate risk thyroid nodule/focal lesion US pattern. A. Ultrasound picture of the thyroid lesion (B-mode). The scoring system -
5.5 points (intermediate risk US pattern≥ 4 < 7 points); C1 – microcalcifications; O – orientation - “taller-than-wide” shape – not shown in the
figure; E – hypoechogenicity; H – the absence of “halo”; C2 – solid composition; D – diameter - below 3 cm (not shown); M – irregular margin;
FNAB cytology in this case - category IV TBSRTC; management - recommend surgery. B. Ultrasound picture of the thyroid lesion (Power Doppler).
The scoring system - 5.5 points (intermediate risk US pattern≥ 4 < 7 points); V – the increased intranodular blood flows.
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nant vs benign).
Taking into account our own observations, in juxtapos-
ition with the opinions of other authors [4,5,19,20,25-27],
we propose a division of US features into 3 groups of
different prognostic importance. Accordingly, microcal-
cifications, “taller-than-wide” orientation, the incorrect
pattern of vascularisation, and hypoechogenicity constitute
one group - each of the features in this group is awarded 1
point. In turn, the characteristics of minor prognostic
importance, such as irregular margin, absence of halo, solidcomposition, and large size (a diameter longer than
3.0 cm) - are associated with the granting 0.5 points each.
The most important prognostic features – a rapid growth
resulting in the enlargement of nodules/focal lesions, as
well as a presence of pathologically altered lymph nodes
are associated with the granting 3 points for each (Table 3).
Having assigned the points for each characteristics, we
created the scoring system that is applied for better as-
sessment of thyroid US patterns in whole.
A total score constitutes the basis to assign the pa-
tients to groups of varying degree of the risk of
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ging from 0 to less than 4 points belong to the group of
low risk US pattern, patients with a score from 4 to less
than 7 points represent US pattern of intermediate risk of
malignancy, and in patients with a score 7 points and
more – US pattern of a high risk of malignancy occurs
(Table 4).
We have illustrated the practical application of our
scoring system of the thyroid US patterns in Figures 2A,
2B, 3A, 3B, 4A and 4B.Figure 4 High risk thyroid nodule/focal lesion US pattern. A. Ultrasoun
system - 7.5 points (high risk US pattern≥ 7 points); C1 – microcalcification
the figure; V - the increased intranodular blood flows; E – hypoechogenicit
below 3 cm (not shown); M – irregular margin; FNAB cytology in this case
B. Ultrasound picture of the metastatic lymph node in the same case (B-m
pattern≥ 7 points); the increased blood flows, mainly peripheral, in the meDiscussion
It is well known that none of the individual US features
allows to differentiate malignant from benign thyroid le-
sions. However, finding in US image of nodule/focal
lesion one (1) or more than one suspicious features, cor-
relates well with the risk of malignancy. This fact is
commonly used for the qualification of patients with
nodules/focal lesions for FNAB cytology.
The current system of cytological diagnoses (TBSRTC)
greatly facilitates therapeutic decisions (Table 5) [6]. Thisd picture of the thyroid lesion (B-mode, Power Doppler). The scoring
s; O – orientation – shape other than “taller-than-wide” – not shown in
y; H – the absence of “halo”; C2 – solid composition; D – diameter -
- category V TBSRTC; management - recommend surgery.
ode, Power Doppler). The scoring system - 7.5 points (high risk US
tastatic lymph node.
Table 5 The Bethesda System for Reporting Thyroid
Cytopathology (TBSRTC) – according to Cibas and Ali [6]
Diagnostic category Risk of malignancy (%)
I Nondiagnostic or unsatisfactory 1-4
II Benign 0-3
III Atypia of undetermined significance or
follicular lesion of undetermined significance
5-15
IV Follicular neoplasm or suspicious for a
follicular neoplasm
15-30
V Suspicious for malignancy 60-75
VI Malignant 97-99
Adamczewski and Lewiński Thyroid Research 2013, 6:6 Page 8 of 10
http://www.thyroidresearchjournal.com/content/6/1/6applies mainly to diagnoses of malignant lesions (category
VI TBSRTC) or a suspicion of malignancy (category V
TBSRTC) which both create the need for urgent referral
for surgery, in order to perform a total thyroidectomy, ex-
cept cases inoperable at the time of diagnosis.
Significantly more difficulties with making a thera-
peutic decision appear when FNAB belongs to the cat-
egory IV TBSRTC - "follicular neoplasm or suspicious
for a follicular neoplasm " or to category III TBSRTC -
"follicular lesion of undetermined significance/atypia of
undetermined significance". These diagnoses require a
completely different clinical approach. Category IV
TBSRTC is believed to be a final result, confirmed by
the opinion of two independent pathologists. Repeating
FNAB in such cases is not expected to provide additional
benefits, thus, a repeated FNAB should be performed only
in case of changes in the US pattern of lesions. The diag-
nosis of category III TBSRTC is "a category of exclusion"
and should be treated as an optional diagnosis, thus, it can
only ultimately be used. The main difference - when com-
pared to category IV - is that category III requires a repeatTotal score US pattern FNAB  category (TBSRTC
0 < 4 points low risk I
II, III
IV
≥ 4 < 7 points intermediate risk I
II
III, IV
≥ 7 points high risk I, II, III, IV
Any lesion, any US pattern V, VI
Figure 5 The algorithm of diagnostic and therapeutic management inbiopsy, like in case nondiagnostic or unsatisfactory FNAB
results (category I TBSRTC). One cannot forget that even
in the case of benign lesions (category II TBSRTC) false-
negative results are still possible and a risk of malignancy
in such cases reaches up to 3% [6].
However, it should be emphasized that the thyroid US
and FNAB cytology are diagnostic tests that should not
always decide about the fate of our patient and about
recommending him/her the surgical treatment. Many
clinical parameters have long been recognized as predic-
tors of malignancy in patients with thyroid nodules/le-
sions. Such factors include family medical history (genetic
background), age younger than 20 and older than 60 years,
irradiation of the neck and head area (particularly in the
childhood) and male sex [4,18,28]. Moreover, certain clin-
ical circumstances, e.g., if the patient complains of hoarse-
ness (which is not a result of stricte laryngeal disease), or
of ache in the tumour and dysphagia - usually caused by a
firm thyroid tumour, may indicate a malignant character
of lesion and may require an inquisitive intense diagnos-
tics of any type, and appropriate treatment, in most cases
of the radical type.
Based on the results of our observations, in combination
with data of other authors, we decided to stratificate the
risk of malignancy, depending on the ascertained signs
and symptoms, US features, FNAB results according to
TBSRTC categories, and – in consequence - we created
the algorithm of diagnostic and therapeutic management,
the use of which seems to be most favourable for patients
with thyroid problems (nodules/focal lesions) (Figure 5).
We are aware of the fact that the assumption underlying
of this study, namely comparison of distribution of US
characteristics in the two groups of the same number of ex-
amined lesions, does not apply in the real epidemiological) Recommendation for further management
FNAB examination after 6 months
Observation FNAB examination after 18 months 
(category II TBSRTC) or after 6-12 months
(category III TBSRTC)
Observation or consider surgery
Repeat FNAB examination after 3 months
(sometimes sooner) or consider surgery
Observation and FNAB examination every 12 months
Recommend surgery
Recommend surgery, except of inoperable cases
Recommend surgery, except of inoperable cases
thyroid nodules/focal lesions.
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study highlights the most important US characteristics, the
presence of which correlates - to the greatest extent - with
the risk of malignancy. The presented algorithm of manage-
ment in patients with thyroid problems is designed to high-
light the complementarity of diagnostic procedures, such as
US and FNAB. Simultaneously, we would like to stress that
US is not only a tool used for selection of nodules which
should be examined by FNAB but is also a diagnostic
method, the outcomes of which can constitute a basis for
the final therapeutic decision.
Conclusions
The presented algorithm, as many other previously de-
veloped to assess the nature of thyroid lesions, does not
solve all the possible encountered clinical problems.
However, by taking into consideration the important US
characteristics, related to an increased risk of malig-
nancy, in combination with cytological assessment of le-
sions, at the same time - by paying attention on the
significance of clinical data from medical history and
physical examination, it fulfils expectations in daily clin-
ical practice and is helpful in making the proper diag-
nostic and therapeutic decisions.
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